JaxBio Technologies, a Netanya, Israel-based medical diagnostics firm, obtained a €2.5M grant from the European Innovation Council (EIC) Accelerator.
This grant included the choice for future blended financing, with a possible further €9.1M from the EU and an identical €9.1M from different buyers.
The corporate intends to make use of the funds to increase scientific applications and develop its diagnostics platform to create a blood check for making lung most cancers detection and administration easier, faster, and extremely correct.
Led by CEO and Founder Dr. Shahar Zirkin, JaxBio is creating a blood check for delicate analysis of most cancers and different illnesses. Its liquid biopsy expertise can detect hundreds of most cancers biomarkers in blood with excessive sensitivity and low price to boost analysis, monitoring, and remedy prediction. This lab course of delivers next-day outcomes, enabling faster, better-informed selections for healthcare suppliers and sufferers when time is vital.
FinSMEs
17/07/2024
